What Happened
The Food and Drug Administration issued a public notification on May 7, 2026, warning consumers not to purchase or use Hard AF!, a dietary supplement marketed for male sexual enhancement. FDA laboratory analysis confirmed the product contains two undeclared prescription drug ingredients: sildenafil and tadalafil, neither of which appear on the product label. The product has been sold through various websites and retail outlets, including major online retailers. This marks a second enforcement action against Hard AF!—the FDA previously issued a public notification on December 8, 2021, when the same product was found to contain sildenafil and acetaminophen.
What the FDA Says
Sildenafil and tadalafil are the active pharmaceutical ingredients in the prescription drugs Viagra and Cialis, respectively, approved only for treating erectile dysfunction under medical supervision. According to the FDA's analysis, the critical safety hazard involves interaction between these hidden drugs and nitrates—medications commonly prescribed for heart conditions such as angina and high blood pressure. When sildenafil or tadalafil combine with nitrates like nitroglycerin, the result can be a dangerous, potentially life-threatening drop in blood pressure. The FDA notes that people with diabetes, high blood pressure, high cholesterol, and heart disease—populations at highest risk from this interaction—often take nitrate medications, yet consumers using Hard AF! would have no knowledge they were ingesting prescription PDE-5 inhibitors.
Beyond the Headline
The Hard AF! case reflects a persistent problem in the dietary supplement industry: deliberate adulteration with undisclosed pharmaceutical ingredients. Male enhancement supplements have become a particular enforcement focus because manufacturers routinely add prescription drugs to create rapid pharmacological effects. Unlike legitimate herbal ingredients such as tribulus terrestris, horny goat weed, or ginseng—which have limited clinical evidence and may show effects only after weeks of use—sildenafil and tadalafil produce immediate results through well-understood drug mechanisms.
The product's continued circulation despite the 2021 FDA warning illustrates enforcement challenges. Supplement sellers operating internationally can repackage or rebrand products and resume distribution through online channels that are difficult to monitor comprehensively. Dietary supplements are regulated differently from pharmaceutical drugs, with manufacturers bearing less responsibility for pre-market safety testing. The FDA can only act after a product enters commerce, relying on adverse event reports, laboratory testing, or consumer complaints. This reactive regulatory model, combined with rapid growth in online sales and complex international supply chains, allows adulterated products to reach consumers before enforcement action takes effect.
What This Means for Consumers
If you have purchased or used Hard AF!, take immediate action if you experience symptoms such as sudden vision loss, chest pain, severe dizziness, fainting, or unusually low blood pressure. Seek emergency medical attention immediately and inform healthcare providers that you may have ingested sildenafil and/or tadalafil. Do not wait for symptoms to worsen; the combination of hidden prescription drugs with cardiovascular conditions or nitrate medications can be medically serious.
If you take any nitrate-based medication (such as nitroglycerin for angina), have heart disease, high blood pressure, high cholesterol, or diabetes, do not use Hard AF! or any untested male enhancement supplement. Inform your healthcare provider about any male enhancement products you have used, even if you have no current symptoms. Report any adverse events from Hard AF! to the FDA's MedWatch Safety Information and Adverse Event Reporting Program online or by fax at 1-800-FDA-0178.
What to Watch Next
The FDA continues monitoring for additional batches or rebranded versions of Hard AF! circulating in the market. Consumers should exercise extreme caution before purchasing any male enhancement supplement, particularly those marketed as "all natural" or without clear ingredient labeling. Request a complete ingredient list and third-party laboratory analysis before use. The agency encourages healthcare providers to ask patients about male enhancement supplement use during routine medical consultations, particularly when prescribing nitrate medications or managing cardiovascular conditions. Additional FDA public notifications regarding adulterated sexual enhancement products are expected as laboratory testing continues on products submitted for analysis.